These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 27729459)

  • 21. Methylation analysis in spontaneous sputum for lung cancer diagnosis.
    Hubers AJ; van der Drift MA; Prinsen CF; Witte BI; Wang Y; Shivapurkar N; Stastny V; Bolijn AS; Hol BE; Feng Z; Dekhuijzen PN; Gazdar AF; Thunnissen E
    Lung Cancer; 2014 May; 84(2):127-33. PubMed ID: 24598366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
    Liu F; Lu X; Zhou X; Huang H
    Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.
    Diaz-Lagares A; Mendez-Gonzalez J; Hervas D; Saigi M; Pajares MJ; Garcia D; Crujerias AB; Pio R; Montuenga LM; Zulueta J; Nadal E; Rosell A; Esteller M; Sandoval J
    Clin Cancer Res; 2016 Jul; 22(13):3361-71. PubMed ID: 26842235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis.
    Chen B; Ying X; Bao L
    Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
    Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
    J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation of genes in sputum samples as diagnostic biomarkers for non-small cell lung cancer: a meta-analysis.
    Wang X; Ling L; Su H; Cheng J; Jin L
    Asian Pac J Cancer Prev; 2014; 15(11):4467-74. PubMed ID: 24969871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.
    Xie Y; Todd NW; Liu Z; Zhan M; Fang H; Peng H; Alattar M; Deepak J; Stass SA; Jiang F
    Lung Cancer; 2010 Feb; 67(2):170-6. PubMed ID: 19446359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
    Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
    J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study.
    Wever BMM; Bach S; Tibbesma M; Ter Braak TJ; Wajon D; Dickhoff C; Lissenberg-Witte BI; Hulbert A; Kazemier G; Bahce I; Steenbergen RDM
    Lung Cancer; 2022 Aug; 170():156-164. PubMed ID: 35793574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymerase chain reaction - surface-enhanced Raman spectroscopy (PCR-SERS) method for gene methylation level detection in plasma.
    Li X; Yang T; Li CS; Song Y; Wang D; Jin L; Lou H; Li W
    Theranostics; 2020; 10(2):898-909. PubMed ID: 31903158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene promoter methylation in plasma and sputum increases with lung cancer risk.
    Belinsky SA; Klinge DM; Dekker JD; Smith MW; Bocklage TJ; Gilliland FD; Crowell RE; Karp DD; Stidley CA; Picchi MA
    Clin Cancer Res; 2005 Sep; 11(18):6505-11. PubMed ID: 16166426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a methylation gene panel by quantitative PCR for lung cancers.
    Shivapurkar N; Stastny V; Suzuki M; Wistuba II; Li L; Zheng Y; Feng Z; Hol B; Prinsen C; Thunnissen FB; Gazdar AF
    Cancer Lett; 2007 Mar; 247(1):56-71. PubMed ID: 16644104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
    Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
    Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
    Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.
    Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J
    Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum.
    Belinsky SA; Grimes MJ; Casas E; Stidley CA; Franklin WA; Bocklage TJ; Johnson DH; Schiller JH
    Br J Cancer; 2007 Apr; 96(8):1278-83. PubMed ID: 17406356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.